Farrell Michael J.
- SEC CIK
- 0001485164
In the past year, 12 open-market sale filings worth $15.7M and no purchases.
Current role at each company
- RMD Resmed IncChairman and CEOas of Sep 10, 2026
- ZBH Zimmer Biomet Holdings, Inc.Directoras of Jul 2, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $15.7M
- 12 filings
- Net
- −$15.7M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Farrell Michael J. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
RMD Resmed Inc
Chairman and CEO53 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 17, 2021 (view filing) | Dec 15 | 2 days | Farrell Michael J.Chief Executive Officer | SSaleResMed Common Stock | −5.67K | $255.53 | −$1.45M | −1.4%405.2K after | |
| Jan 20, 2022 (view filing) | Jan 18 | 2 days | Farrell Michael J.Chief Executive Officer | SSaleResMed Common Stock | −5.67K | $241.94 | −$1.37M | −1.4%405.2K after | |
| Feb 16, 2022 (view filing) | Feb 15 | 1 day | Farrell Michael J.Chief Executive Officer | SSaleResMed Common Stock | −5.67K | $234.06 | −$1.33M | −1.4%405.2K after | |
| Mar 16, 2022 (view filing) | Mar 15 | 1 day | Farrell Michael J.Chief Executive Officer | SSaleResMed Common Stock | −5.67K | $242.37 | −$1.38M | −1.4%405.2K after | |
| Apr 19, 2022 (view filing) | Apr 18 | 1 day | Farrell Michael J.Chief Executive Officer | SSaleResMed Common Stock | −5.67K | $232.41 | −$1.32M | −1.4%405.2K after | |
| May 17, 2022 (view filing) | May 16 | 1 day | Farrell Michael J.Chief Executive Officer | SSaleResMed Common Stock | −5.67K | $196.61 | −$1.12M | −1.4%405.3K after | |
| Jun 16, 2022 (view filing) | Jun 15 | 1 day | Farrell Michael J.Chief Executive Officer | SSaleResMed Common Stock | −5.67K | $202.54 | −$1.15M | −1.4%405.3K after | |
| Jul 18, 2022 (view filing) | Jul 15 | 3 days | Farrell Michael J.Chief Executive Officer | SSaleResMed Common Stock | −5.67K | $224.94 | −$1.28M | −1.4%405.3K after | |
| Aug 17, 2022 (view filing) | Aug 15 | 2 days | Farrell Michael J.Chief Executive Officer | SSaleResMed Common Stock | −5.67K | $238.09 | −$1.35M | −1.4%405.3K after | |
| Sep 19, 2022 (view filing) | Sep 15 | 4 days | Farrell Michael J.Chief Executive Officer | SSaleResMed Common Stock | −5.67K | $228.96 | −$1.30M | −1.3%422.6K after |